Visterra Inc.

Visterra Inc.

Visterra Inc.

Visterra researches on and develops therapeutic and diagnostic products for thetreatment of infectious diseases.
Type
B2c
Founded
2007
Raised
$67.7M
Follow us
Alexa global traffic share
Acquired by
Otsuka Pharmaceutical Company Limited
1
Latest funding Show all
$23,600,000
Venture capital (Series C) - 2017
Flagship Ventures Polaris Partners Cycad Group +8
$30,000,000
Venture capital (Series B) - 2014
Flagship Ventures Polaris Partners Cycad Group +5
$430,000,000
PE HUB

Otsuka completes Visterra acquisition for about $430 mln

PE HUB

Otsuka to buy VC-backed Visterra for about $430 mln

Health
$23,600,000 Venture capital (Series C)
PE HUB

CTI Life Sciences invests in Visterra's $46.7 mln Series C

Health Funding
Xconomy

Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs

Health Stock markets